Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc.verified

VVOS

Price:

$0.572

Market Cap:

$3.37M

Vivos Therapeutics, Inc. is a medical technology enterprise dedicated to developing and commercializing advanced treatment solutions for adults facing conditions like dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring. The company's flagship product, the Vivos System, offers a unique multi-disciplinary therapy that stands out for being non-invasive, non-surgical, and free of pharmaceuticals, specifically addressing these dentofacial and sleep-related issues. Additionally, Vivos Therapeutics provides the VivoScore Program, a service encompassing comprehensive screening and convenient home sleep tests for both adults and children. The Vivos System is distributed and sold to ...[Read more]

Industry

Medical - Devices

IPO Date

2020-12-11

Stock Exchange

NASDAQ

Ticker

VVOS

The Enterprise Value as of June 2026 (TTM) for Vivos Therapeutics, Inc. (VVOS) is 13.53M

According to Vivos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 13.53M. This represents a change of -60.52% compared to the average of 34.26M of the last 4 quarters.

Vivos Therapeutics, Inc. (VVOS) Historical Enterprise Value (quarterly & annually)

How has VVOS Enterprise Value performed in the past?

The mean historical Enterprise Value of Vivos Therapeutics, Inc. over the last ten years is 50.87M. The current 13.53M Enterprise Value has changed 2.56% with respect to the historical average. Over the past ten years (40 quarters), VVOS's Enterprise Value was at its highest in in the December 2019 quarter at 114.97M. The Enterprise Value was at its lowest in in the March 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

50.87M

Median

28.85M

Minimum

8.14M

Maximum

114.81M

Vivos Therapeutics, Inc. (VVOS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vivos Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 92.58%

Maximum Annual Enterprise Value = 114.81M

Minimum Annual Increase = -72.02%

Minimum Annual Enterprise Value = 8.14M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202532.33M92.58%
202416.79M8.16%
202315.52M90.56%
20228.14M-67.90%
202125.38M-72.02%
202090.70M-21.00%
2019114.81M11.20%

Vivos Therapeutics, Inc. (VVOS) Average Enterprise Value

How has VVOS Enterprise Value performed in the past?

The current Enterprise Value of Vivos Therapeutics, Inc. (VVOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

21.55M

5-year avg

19.63M

10-year avg

50.87M

Vivos Therapeutics, Inc. (VVOS) Enterprise Value vs. Peers

How is VVOS’s Enterprise Value compared to its peers?

Vivos Therapeutics, Inc.’s Enterprise Value is less than Allurion Technologies Inc. (29.37M), greater than enVVeno Medical Corporation (-1828970.00), greater than Co-Diagnostics, Inc. (-1411934.00), greater than Aethlon Medical, Inc. (-3151952.00), greater than Envoy Medical, Inc. (-11301680.00), less than Adagio Medical Holdings, Inc. (22.52M), greater than OSR Holdings, Inc. (12.75M), less than Adlai Nortye Ltd. (550.38M), greater than Lipocine Inc. (8.10M), less than American Shared Hospital Services (25.37M),

Build a custom stock screener for Vivos Therapeutics, Inc. (VVOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vivos Therapeutics, Inc. (VVOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vivos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Vivos Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Vivos Therapeutics, Inc. (VVOS)?

What is the 3-year average Enterprise Value for Vivos Therapeutics, Inc. (VVOS)?

What is the 5-year average Enterprise Value for Vivos Therapeutics, Inc. (VVOS)?

How does the current Enterprise Value for Vivos Therapeutics, Inc. (VVOS) compare to its historical average?